Valuation: Celltrion, Inc.

Market Cap 41,712B 30.97B 27.52B 25.68B 23.41B 44.15B 2,977B 44.56B 311B 120B 1,522B 116B 114B 4,885B P/E 2026 *
27.6x
P/E 2027 * 23.7x
Enterprise Value 43.91B 32.6M 28.97M 27.04M 24.64M 46.48M 3.13B 46.91M 327M 127M 1.6B 122M 120M 5.14B EV / Sales 2026 *
7.93x
EV / Sales 2027 * 6.78x
Free-Float
60.59%
Yield 2026 *
0.41%
Yield 2027 * 0.43%
1 day-0.54%
1 week+2.93%
Current month+2.76%
1 month-1.99%
3 months+3.40%
6 months-2.53%
Current year+5.93%
1 week 175,500
Extreme 175500
184,200
1 month 174,600
Extreme 174600
190,000
Current year 158,500
Extreme 158500
239,047.62
1 year 158,500
Extreme 158500
239,047.62
3 years 114,250.83
Extreme 114250.828535
239,047.62
5 years 114,250.83
Extreme 114250.828535
239,047.62
10 years 64,487.59
Extreme 64487.593381
325,235.48
Manager TitleAgeSince
Chief Executive Officer 65 20/03/2015
Chief Executive Officer 42 26/03/2021
President 51 13/02/2026
Director TitleAgeSince
Chairman 69 -
Director/Board Member 61 01/04/2005
Director/Board Member 66 -
Date Insider Type Main position Quantity % Market Cap. Importance
1/16/26 A Sell 500 0.0002%
1/16/26 A Sell 1,000 0.0004%
1/16/26 A Sell 1,000 0.0004%
Change 5-day change 1-year change 3-year change Capi.($)
-0.54%+2.93%+9.31%+50.41% 30.97B
+4.16%+3.04%+49.37%+94.17% 74.16B
-3.11%-3.53%+21.92%+74.60% 57.39B
+0.89%-0.63%+4.28%+34.51% 47.64B
+0.36%+0.81%+352.17%+689.61% 44.29B
-0.96%-4.50%+26.36%+33.18% 42.5B
-0.20%-0.77%+3.74%+100.60% 40.71B
-2.68%+2.92%+29.63%+19.50% 28.53B
+0.05%-1.64%-7.28%-14.06% 24.34B
+2.33%-5.69%-27.28%+338.00% 24.27B
Average +0.03%-1.10%+46.22%+142.05% 41.48B
Weighted average by Cap. +0.25%-1.12%+53.73%+142.08%

Financials

2026 *2027 *
Net sales 5,535B 4.11B 3.65B 3.41B 3.11B 5.86B 395B 5.91B 41.24B 15.98B 202B 15.43B 15.1B 648B 6,350B 4.71B 4.19B 3.91B 3.56B 6.72B 453B 6.78B 47.32B 18.33B 232B 17.7B 17.32B 744B
Net income 1,538B 1.14B 1.01B 947M 863M 1.63B 110B 1.64B 11.46B 4.44B 56.11B 4.29B 4.19B 180B 1,780B 1.32B 1.17B 1.1B 999M 1.88B 127B 1.9B 13.26B 5.14B 64.95B 4.96B 4.85B 208B
Net Debt 2,198B 1.63B 1.45B 1.35B 1.23B 2.33B 157B 2.35B 16.38B 6.35B 80.19B 6.13B 5.99B 257B 1,318B 979M 870M 812M 740M 1.4B 94.08B 1.41B 9.82B 3.81B 48.1B 3.67B 3.59B 154B
Logo Celltrion, Inc.
Celltrion Inc is a Korea-based company mainly engaged in the production and sale of bio pharmaceuticals. The Company operates its business through two segments. The Bio Pharmaceutical segment produces and sells protein therapeutics such as anticancer drugs. In addition, this Segment develops monoclonal antibodies(mABs) that are used to treat chronic autoimmune diseases such as arthritis and severe diseases such as breast and colon cancer. The Chemical Pharmaceutical segment is mainly engaged in the manufacture and sale of chemical drugs. In addition, the Segment sells bio drugs, and provides services such as data analysis. The Company's main products include liver and bowel medicines and other generics. The main products sold by the Company include autoimmune disease treatment agents, anti-malignant tumor drugs and other products. The Company sells its products in domestic and overseas markets such as Europe and the United States.
Employees
2,956
Date Price Change Volume
02/10/26 ₩182,600.00 -0.54% 319,980
01/10/26 ₩183,600.00 +3.32% 422,088
30/09/26 ₩177,700.00 -0.67% 352,051
29/09/26 ₩178,900.00 +0.34% 298,374
28/09/26 ₩178,300.00 +0.51% 267,873
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
182,600.00KRW
Average target price
267,741.48KRW
Spread / Average Target
+46.63%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A068270 Stock